G1 Therapeutics Inc (GTHX)
NASDAQ:GTHX
Holding GTHX?
Track your performance easily

G1 Therapeutics (GTHX) Financial Statements

1,886 Followers

G1 Therapeutics Financial Overview

G1 Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.861; its P/E ratio is -8.30; G1 Therapeutics is scheduled to report earnings on October 30, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 16.55M$ 14.48M$ 14.87M$ 12.30M$ 42.39M
Gross Profit$ 16.55M$ 13.40M$ 13.62M$ 12.30M$ 42.39M
EBIT$ -769.00K$ -8.24M$ -7.85M$ -17.30M$ 10.02M
EBITDA$ -161.00K$ -8.12M$ -7.73M$ -17.47M$ 9.86M
Net Income Common Stockholders$ -5.47M$ -10.22M$ -10.88M$ -18.20M$ 8.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 60.73M$ 65.19M$ 82.16M$ 94.35M$ 104.29M
Total Assets$ 98.69M$ 102.03M$ 121.54M$ 133.10M$ 147.89M
Total Debt$ 47.95M$ 47.04M$ 55.90M$ 55.92M$ 55.93M
Net Debt$ -12.78M$ -18.14M$ -26.26M$ -38.43M$ -48.36M
Total Liabilities$ 74.08M$ 74.29M$ 86.15M$ 90.08M$ 90.34M
Stockholders Equity$ 24.57M$ 27.74M$ 35.39M$ 43.02M$ 57.55M
Cash Flow-
Free Cash Flow$ -5.27M$ -8.90M$ -12.79M$ -10.58M$ 14.09M
Operating Cash Flow$ -5.27M$ -8.90M$ -12.79M$ -10.58M$ 14.09M
Investing Cash Flow$ 229.00K$ 5.29M$ -7.65M$ 7.20M$ 346.00K
Financing Cash Flow$ 232.00K$ -8.72M$ 34.00K$ 22.00K$ -26.75M
Currency in USD

G1 Therapeutics Earnings and Revenue History

G1 Therapeutics Debt to Assets

G1 Therapeutics Cash Flow

G1 Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis